Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dihydro montelukast is a potential impurity found in commercial montelukast preparations. Montelukast (sodium salt) is a potent and selective cysteinyl leukotriene 1 (CysLT1) receptor antagonist. Formulations containing montelukast are used for the treatment of asthma as well as for the symptoms associated with allergic rhinitis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
500 μg | 35 days | $ 243.00 | |
1 mg | 35 days | $ 438.00 |
Description | Dihydro montelukast is a potential impurity found in commercial montelukast preparations. Montelukast (sodium salt) is a potent and selective cysteinyl leukotriene 1 (CysLT1) receptor antagonist. Formulations containing montelukast are used for the treatment of asthma as well as for the symptoms associated with allergic rhinitis. |
Molecular Weight | 588.2 |
Formula | C35H38ClNO3S |
CAS No. | 142147-67-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Chloroform: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dihydro Montelukast 142147-67-9 inhibitor inhibit